285 related articles for article (PubMed ID: 11389491)
1. Randomized, double-blind, controlled study of cefoperazone-sulbactam plus cotrimoxazole versus ceftazidime plus cotrimoxazole for the treatment of severe melioidosis.
Chetchotisakd P; Porramatikul S; Mootsikapun P; Anunnatsiri S; Thinkhamrop B
Clin Infect Dis; 2001 Jul; 33(1):29-34. PubMed ID: 11389491
[TBL] [Abstract][Full Text] [Related]
2. Cefoperazone/sulbactam + co-trimoxazole vs ceftazidime + co-trimoxazole in the treatment of severe melioidosis: a randomized, double-blind, controlled study.
Thamprajamchit S; Chetchotisakd P; Thinkhamrop B
J Med Assoc Thai; 1998 Apr; 81(4):265-71. PubMed ID: 9623020
[TBL] [Abstract][Full Text] [Related]
3. Two randomized controlled trials of ceftazidime alone versus ceftazidime in combination with trimethoprim-sulfamethoxazole for the treatment of severe melioidosis.
Chierakul W; Anunnatsiri S; Short JM; Maharjan B; Mootsikapun P; Simpson AJ; Limmathurotsakul D; Cheng AC; Stepniewska K; Newton PN; Chaowagul W; White NJ; Peacock SJ; Day NP; Chetchotisakd P
Clin Infect Dis; 2005 Oct; 41(8):1105-13. PubMed ID: 16163628
[TBL] [Abstract][Full Text] [Related]
4. The role of cefoperazone-sulbactam for treatment of severe melioidosis.
Apisarnthanarak A; Little JR
Clin Infect Dis; 2002 Mar; 34(5):721-3. PubMed ID: 11823963
[No Abstract] [Full Text] [Related]
5. Differential antibiotic-induced endotoxin release in severe melioidosis.
Simpson AJ; Opal SM; Angus BJ; Prins JM; Palardy JE; Parejo NA; Chaowagul W; White NJ
J Infect Dis; 2000 Mar; 181(3):1014-9. PubMed ID: 10720525
[TBL] [Abstract][Full Text] [Related]
6. Relapse in melioidosis: incidence and risk factors.
Chaowagul W; Suputtamongkol Y; Dance DA; Rajchanuvong A; Pattara-arechachai J; White NJ
J Infect Dis; 1993 Nov; 168(5):1181-5. PubMed ID: 8228352
[TBL] [Abstract][Full Text] [Related]
7. Comparison of imipenem and ceftazidime as therapy for severe melioidosis.
Simpson AJ; Suputtamongkol Y; Smith MD; Angus BJ; Rajanuwong A; Wuthiekanun V; Howe PA; Walsh AL; Chaowagul W; White NJ
Clin Infect Dis; 1999 Aug; 29(2):381-7. PubMed ID: 10476746
[TBL] [Abstract][Full Text] [Related]
8. [Comparison of efficacy between ceftriaxone and cefoperazone plus sulbactam in peri-operative treatment of acute suppurative cholangitis].
Zhou XS; Zou SQ; Dong JH; Wu WZ; Zhang YD; Zhang TL; Zeng Z; Li NF; Man GT
Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(22):1879-82. PubMed ID: 15631798
[TBL] [Abstract][Full Text] [Related]
9. Cefoperazone-sulbactam for treatment of intra-abdominal infections: results from a randomized, parallel group study in India.
Chandra A; Dhar P; Dharap S; Goel A; Gupta R; Hardikar JV; Kapoor VK; Mathur AK; Modi P; Narwaria M; Ramesh MK; Ramesh H; Sastry RA; Shah S; Virk S; Sudheer OV; Sreevathsa MR; Varshney S; Kochhar P; Somasundaram S; Desai C; Schou M
Surg Infect (Larchmt); 2008 Jun; 9(3):367-76. PubMed ID: 18570578
[TBL] [Abstract][Full Text] [Related]
10. Activity of tigecycline in the treatment of acute Burkholderia pseudomallei infection in a murine model.
Feterl M; Govan B; Engler C; Norton R; Ketheesan N
Int J Antimicrob Agents; 2006 Nov; 28(5):460-4. PubMed ID: 17046208
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary melioidosis presenting with right paratracheal mass.
Reechaipichitkul W
Southeast Asian J Trop Med Public Health; 2004 Jun; 35(2):384-7. PubMed ID: 15691141
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness study comparing cefoperazone-sulbactam to a three-drug combination for treating intraabdominal infections in an Indian health-care setting.
Kochhar P; Suvarna V; Duttagupta S; Sarkar S
Value Health; 2008 Mar; 11 Suppl 1():S33-8. PubMed ID: 18387065
[TBL] [Abstract][Full Text] [Related]
13. In-vitro susceptibility of Burkholderia pseudomallei to cefoperazone-sulbactam combination.
Koay AS; Rohani MY; Cheong YM
Med J Malaysia; 1997 Jun; 52(2):158-60. PubMed ID: 10968074
[TBL] [Abstract][Full Text] [Related]
14. In vitro interactions between cotrimoxazole and doxycycline in Burkholderia pseudomallei: how important is this combination in maintenance therapy of melioidosis?
Saraya S; Soontornpas C; Chindavijak B; Mootsikapun P
Indian J Med Microbiol; 2009; 27(1):88-9. PubMed ID: 19172079
[No Abstract] [Full Text] [Related]
15. A comparison of chloramphenicol, trimethoprim-sulfamethoxazole, and doxycycline with doxycycline alone as maintenance therapy for melioidosis.
Chaowagul W; Simpson AJ; Suputtamongkol Y; Smith MD; Angus BJ; White NJ
Clin Infect Dis; 1999 Aug; 29(2):375-80. PubMed ID: 10476745
[TBL] [Abstract][Full Text] [Related]
16. Melioidosis: advances in diagnosis and treatment.
Cheng AC
Curr Opin Infect Dis; 2010 Dec; 23(6):554-9. PubMed ID: 20847695
[TBL] [Abstract][Full Text] [Related]
17. Spectrum of melioidosis in the suburbs of Mangalore, S West Coast of India.
Antony B; Pinto H; Dias M; Shetty AK; Scaria B; Kuruvilla T; Boloor R
Southeast Asian J Trop Med Public Health; 2010 Jan; 41(1):169-74. PubMed ID: 20578496
[TBL] [Abstract][Full Text] [Related]
18. Melioidosis presenting as sepsis syndrome: a case report.
Redondo MC; Gómez M; Landaeta ME; Ríos H; Khalil R; Guevara RN; Palavecino S; Figuera M; Caldera J; Rivera R; Calvo A; Vitelli J; Morón M; Nuñez MJ
Int J Infect Dis; 2011 Mar; 15(3):e217-8. PubMed ID: 21195650
[TBL] [Abstract][Full Text] [Related]
19. Out of hospital treatment of patients with melioidosis using ceftazidime in 24 h elastomeric infusors, via peripherally inserted central catheters.
Huffam S; Jacups SP; Kittler P; Currie BJ
Trop Med Int Health; 2004 Jun; 9(6):715-7. PubMed ID: 15189462
[TBL] [Abstract][Full Text] [Related]
20. Burkholderia pseudomallei: the unbeatable foe?
Leelarasamee A
Southeast Asian J Trop Med Public Health; 1998 Jun; 29(2):410-5. PubMed ID: 9886137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]